Torus Biosystems is an infectious disease diagnostics company developing syndromic testing solutions based on the integration of technologies such as qPCR and microarray. It offers Torus Synestia System, which employs the syndromic testing approach, delivers solutions at the patient point of care in a portable system that supports decentralized healthcare settings, and helps guide clinical interventions.